TY - JOUR T1 - Smoking and COVID-19: A two-sample Mendelian randomization study JF - medRxiv DO - 10.1101/2021.03.31.21254730 SP - 2021.03.31.21254730 AU - Bing-Kun Zheng AU - Na Li Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254730.abstract N2 - Evidence from observational studies suggested that smokers are at increased risk of coronavirus disease 2019 (COVID-19). We aimed to assess the causal effect of smoking on risk for COVID-19 susceptibility and severity using two-sample Mendelian randomization method. Smoking-associated variants were selected as instrument variables from two largest genetic studies. The latest summary data of COVID-19 that shared on Jan 18, 2021 by the COVID-19 Host Genetics Initiative was used. The present Mendelian randomization study provided genetic evidence that smoking was a causal risk factor for COVID-19 susceptibility and severity. In addition, there may be a dose-effect relationship between smoking and COVID-19 severity.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval and informed consent were waived by IRB of The First Affiliated Hospital of Zhengzhou University because they were obtained for each of the original study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll analyses were based on publicly available summary data from published genetics studies. ER -